Fidia signed a binding agreement with Sanofi for the acquisition of a portfolio of anti-inflammatory drugs.
Category: Events
Our Four Leading Principles:
Innovation
Quality
Globalization
Competitiveness
The health, well-being and safety of the people we engage with, including you, our customers, partners, and suppliers, as well as all of our employees, continues to be a top priority for Fidia.
Our Four Leading Principles:
Innovation
Quality
Globalization
Competitiveness
Fidia has implemented a series of measures, to minimize any potential risks related with the COVID-19 outbreak, guaranteeing full operations in, from and to the factories, as well as transports of goods and supply of materials.
Our Four Leading Principles:
Innovation
Quality
Globalization
Competitiveness
HYMOVIS® is a highly viscoelastic hydrogel (HYADD®4) engineered using a proprietary process that increases lubrication and shock absorption properties; new data demonstrating long-term benefits of Hymovis® in alleviating osteoarthritis knee pain and stiffness and improving physical function and quality of life will be presented. PARSIPPANY, N.J., July 5, 2016 – Fidia Farmaceutici S.p.A., a world […]